Ali Ismail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Ismail has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Linda Abou-Abbas
Lebanese University
3 shared publications Alaa Masri
Affiliation Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
1 shared publication- Aya Taleb
Lebanese Univ, Fac Med Sci, Neurosci Res Ctr, Beirut, Lebanon
1 shared publication Celine Haddad
Affiliation Faculty of Medical Sciences, Neuroscience Research Center, Lebanese University, Beirut, Lebanon
1 shared publicationFatima Hammoud
Faculty of Medical Sciences, Neuroscience Research Center, Lebanese University, Beirut, Lebanon
1 shared publication- Jad El Masri
Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 30 January 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-14
Exploring the influence of pregnancy on cognitive function in women: a systematic review
Pregnancy has been increasingly recognized for its potential impact on cognitive function influenced significantly by hormonal fluctuations such as estrogen and progesterone. However, the findings from research in this area remain debated, often varying with individual factors and pregnancy trimesters. This study aims to systematically review existing literature and empirical research to better understand the phenomenon known as “pregnancy brain” and its association with cognitive change. We conducted a systematic review of peer-reviewed English language articles sourced from Medline, Cochrane Library, and PubMed. Using search terms (pregnancy OR pregnant) AND (cognit* OR memory OR cognitive function*), we identified relevant articles published from the inception of these databases to July 2023. Due to the diverse outcomes in identified studies, a meta-analysis was not feasible, and therefore, a narrative synthesis was conducted to summarize findings. Screening 3892 studies yielded 31 that met inclusion criteria, encompassing 1596 pregnant women and 1450 non-pregnant controls. Notably, seven studies originated from Australia, of which four were rated as low quality. The aggregated findings suggest that pregnancy modestly affects verbal memory and attention compared to non-pregnant controls, with indications that this decline persists postnatally. Future efforts should prioritize uncovering the underlying mechanisms driving these cognitive changes during pregnancy and consider developing targeted interventions. Such initiatives aim to mitigate potential impacts on maternal well-being, advocating for comprehensive support systems tailored to pregnant individuals navigating cognitive shifts during this transformative period.
- 30 January 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1-14
Top Cited PapersOpen AccessExploring the influence of pregnancy on cognitive function in women: a systematic review
Pregnancy has been increasingly recognized for its potential impact on cognitive function influenced significantly by hormonal fluctuations such as estrogen and progesterone. However, the findings from research in this area remain debated, often varying with individual factors and pregnancy trimesters. This study aims to systematically review existing literature and empirical research to better understand the phenomenon known as “pregnancy brain” and its association with cognitive change. We conducted a systematic review of peer-reviewed English language articles sourced from Medline, Cochrane Library, and PubMed. Using search terms (pregnancy OR pregnant) AND (cognit* OR memory OR cognitive function*), we identified relevant articles published from the inception of these databases to July 2023. Due to the diverse outcomes in identified studies, a meta-analysis was not feasible, and therefore, a narrative synthesis was conducted to summarize findings. Screening 3892 studies yielded 31 that met inclusion criteria, encompassing 1596 pregnant women and 1450 non-pregnant controls. Notably, seven studies originated from Australia, of which four were rated as low quality. The aggregated findings suggest that pregnancy modestly affects verbal memory and attention compared to non-pregnant controls, with indications that this decline persists postnatally. Future efforts should prioritize uncovering the underlying mechanisms driving these cognitive changes during pregnancy and consider developing targeted interventions. Such initiatives aim to mitigate potential impacts on maternal well-being, advocating for comprehensive support systems tailored to pregnant individuals navigating cognitive shifts during this transformative period.
- Open Access
- 1 January 2025
- Published by Wiley in Parkinson's Disease
- Vol. 2025 (1)
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
Background: Research into alternative treatments for Parkinson’s disease (PD) is gaining increasing attention. Mucuna pruriens ( M. pruriens ), a plant traditionally used in Ayurvedic medicine, contains a significant amount of L‐dopa (4%–6%), the primary active component of conventional levodopa (LD) therapy—the gold standard treatment for PD. M. pruriens is also recognized for its anti‐inflammatory, antioxidant, antiapoptotic, and antiparkinsonian properties, which collectively suggest therapeutic benefits for individuals with PD. Objective: This systematic review aims to investigate the efficacy and safety of M. pruriens in managing symptoms of PD. Methods: A comprehensive search was conducted in PubMed, Embase, and Web of Science for clinical trials published up to February 2024. Studies comparing M. pruriens to LD were included. Quality assessment was performed, and findings were synthesized narratively. Results: Out of 466 articles identified, 5 clinical trials involving a total of 108 participants (mean age: 60 years) were included. Quality assessment rated one study as high quality, one as having some concerns, and three as low quality. Despite heterogeneity in M. pruriens interventions, the findings consistently showed improvements in PD symptoms and therapy‐related complications. Treatment with M. pruriens was associated with a shorter time to reach the “on” disease stage, prolonged duration of this stage, and fewer adverse events, with no dyskinesia reported. Conclusion: M. pruriens shows promise in improving motor symptoms and reducing therapy complications in PD patients. However, current clinical evidence is limited, and further high‐quality trials are needed to confirm its efficacy and safety.
- 1 January 2025
- Published by Wiley in Parkinson's Disease
- Vol. 2025 (1)
Open AccessMucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
Background: Research into alternative treatments for Parkinson’s disease (PD) is gaining increasing attention. Mucuna pruriens ( M. pruriens ), a plant traditionally used in Ayurvedic medicine, contains a significant amount of L‐dopa (4%–6%), the primary active component of conventional levodopa (LD) therapy—the gold standard treatment for PD. M. pruriens is also recognized for its anti‐inflammatory, antioxidant, antiapoptotic, and antiparkinsonian properties, which collectively suggest therapeutic benefits for individuals with PD. Objective: This systematic review aims to investigate the efficacy and safety of M. pruriens in managing symptoms of PD. Methods: A comprehensive search was conducted in PubMed, Embase, and Web of Science for clinical trials published up to February 2024. Studies comparing M. pruriens to LD were included. Quality assessment was performed, and findings were synthesized narratively. Results: Out of 466 articles identified, 5 clinical trials involving a total of 108 participants (mean age: 60 years) were included. Quality assessment rated one study as high quality, one as having some concerns, and three as low quality. Despite heterogeneity in M. pruriens interventions, the findings consistently showed improvements in PD symptoms and therapy‐related complications. Treatment with M. pruriens was associated with a shorter time to reach the “on” disease stage, prolonged duration of this stage, and fewer adverse events, with no dyskinesia reported. Conclusion: M. pruriens shows promise in improving motor symptoms and reducing therapy complications in PD patients. However, current clinical evidence is limited, and further high‐quality trials are needed to confirm its efficacy and safety.
- 18 April 2024
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 38 (8) , 2009-2026
Psychometric properties of the Arabic version of the everyday memory questionnaire - revised (EMQ-R) among the Lebanese population
Memory, a fundamental cognitive function, plays a pivotal role in our daily lives, influencing our ability to encode, store, retain information, and recall past experiences (Licu, 2023). Everyday m...
- 18 April 2024
- Published by Taylor & Francis in The Clinical Neuropsychologist
- Vol. 38 (8) , 2009-2026
Psychometric properties of the Arabic version of the everyday memory questionnaire - revised (EMQ-R) among the Lebanese population
Memory, a fundamental cognitive function, plays a pivotal role in our daily lives, influencing our ability to encode, store, retain information, and recall past experiences (Licu, 2023). Everyday m...
- Open Access
- 17 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0297976
Vitamin B12 deficiency and neuropsychiatric symptoms in Lebanon: A cross-sectional study of vegans, vegetarians, and omnivores
Background: Vitamin B12 deficiency is responsible for a variety of complications, particularly neurological/neuropsychiatric complications, including depression, irritability, paresthesia and insomnia. Since vitamin B12 is found in animal-derived products, vegans/vegetarians are at a greater risk for developing vitamin B12 deficiency. Aims: This study aims to investigate the occurrence of vitamin B12 deficiency among a sample of adult Lebanese population, with a particular emphasis on assessing the severity of its neurological/neuropsychiatric signs and symptoms, especially among vegans/vegetarians. Methodology: A cross-sectional study was conducted among a sample of 483 Lebanese adults. Data was collected through a standardized questionnaire that included socio-demographic characteristics, the Patient Health Questionnaire-9 (PHQ-9), Generalized anxiety disorders-7 (GAD-7), and the Insomnia Severity Index (ISI) scales. Results: Among the participants, 11.4% were in the vegan/vegetarian group, and about 43.1% had vitamin B12 deficiency. After analyzing the PHQ-9, GAD-7 and ISI total scores, higher scores were reported in participants with vitamin B12 deficiency, compared to individuals with normal vitamin B12 serum levels (p < 0.001). Regarding the diet type, vegans/vegetarians were more susceptible to developing depression compared to omnivores (mean scores of 11.92 vs 8.02 on the PHQ-9 scale, respectively, with p < 0.001). Of the patients with vitamin B12 deficiency, 81.1% reported having paresthesia compared to 43.7% of individuals with no vitamin B12 deficiency (p < 0.001). Conclusion: Vitamin B12 deficiency in Lebanon is notably high and is linked to an increased risk of developing depression, generalized anxiety disorder, insomnia, and paresthesia. Vegans/vegetarians exhibit a higher susceptibility to developing depression compared to omnivores, whereas the risk of developing insomnia, generalized anxiety disorder and paresthesia was statistically insignificant when comparing vegans/vegetarians to omnivores.
- 17 April 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (4) , e0297976
Open AccessVitamin B12 deficiency and neuropsychiatric symptoms in Lebanon: A cross-sectional study of vegans, vegetarians, and omnivores
Background: Vitamin B12 deficiency is responsible for a variety of complications, particularly neurological/neuropsychiatric complications, including depression, irritability, paresthesia and insomnia. Since vitamin B12 is found in animal-derived products, vegans/vegetarians are at a greater risk for developing vitamin B12 deficiency. Aims: This study aims to investigate the occurrence of vitamin B12 deficiency among a sample of adult Lebanese population, with a particular emphasis on assessing the severity of its neurological/neuropsychiatric signs and symptoms, especially among vegans/vegetarians. Methodology: A cross-sectional study was conducted among a sample of 483 Lebanese adults. Data was collected through a standardized questionnaire that included socio-demographic characteristics, the Patient Health Questionnaire-9 (PHQ-9), Generalized anxiety disorders-7 (GAD-7), and the Insomnia Severity Index (ISI) scales. Results: Among the participants, 11.4% were in the vegan/vegetarian group, and about 43.1% had vitamin B12 deficiency. After analyzing the PHQ-9, GAD-7 and ISI total scores, higher scores were reported in participants with vitamin B12 deficiency, compared to individuals with normal vitamin B12 serum levels (p < 0.001). Regarding the diet type, vegans/vegetarians were more susceptible to developing depression compared to omnivores (mean scores of 11.92 vs 8.02 on the PHQ-9 scale, respectively, with p < 0.001). Of the patients with vitamin B12 deficiency, 81.1% reported having paresthesia compared to 43.7% of individuals with no vitamin B12 deficiency (p < 0.001). Conclusion: Vitamin B12 deficiency in Lebanon is notably high and is linked to an increased risk of developing depression, generalized anxiety disorder, insomnia, and paresthesia. Vegans/vegetarians exhibit a higher susceptibility to developing depression compared to omnivores, whereas the risk of developing insomnia, generalized anxiety disorder and paresthesia was statistically insignificant when comparing vegans/vegetarians to omnivores.